Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease.

Publication date: Feb 14, 2024

Children with very early onset inflammatory bowel disease (VEO-IBD) may respond differently to coronavirus disease 2019 (COVID-19) immunization compared to healthy children or other patients with IBD. We recruited children with VEO-IBD

Concepts Keywords
Coronavirus antibody
Covid COVID-19
Healthy Moderna
Inflammatory Pfizer
Vaccines vaccine


Type Source Name
disease IDO humoral immune response
disease VO vaccination
disease MESH coronavirus disease 2019
disease VO immunization
disease VO vaccine

Original Article

(Visited 1 times, 1 visits today)